Quiere al día Tratamiento de Cáncer Noticias? Suscríbete a nuestro boletín electrónico. Suscríbase ahora!

Share OncoLink

OncoLink Treatment Binder

Seleccione los efectos secundarios y formas de ligante de tratamiento de su paciente

Más información


Preocupado por su cuenta y riesgo de cáncer y cómo reducir su riesgo?

Más información


OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información


OncoLink Survivorship Care Plan

Crear un plan de cuidado de la supervivencia libre de aprender acerca de cómo navegar la vida después del cáncer.

Desarrollar Mi Careplan


OncoLink eNewsletter

Suscríbete a nuestro boletín mensual o leer los archivos.Subscribe to our monthly newsletter or read the archives.

Suscríbase ahora!


What's New

Session II: "I have a headache; it must be cancer." Confronting Anxiety and Fear Associated with Professional Cancer Caregiving and Trauma Exposure
Training module for oncology professionals to promote self care in response to work related stressors.

Session I: It's the most wonderful time of the year? Managing work-life balance during the holiday season
This continuing education activity is designed to enable the learner to understand the challenges of working in oncology and how they can maintain a healthy work-life balance during the holiday season.

Blinatumomab (Blincyto™)
Overview of this bispecific T cell engager that targets CD19, found on B-cell leukemia and lymphomas.


View all What's New OncoLink Cancer Resources RSS What's New RSS Feed

Blogs

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

Recent Posts:



Courage or Desperation?
February 23, 2015


View all Blogs Blogs OncoLink Blog RSS Feed

Webinars

Brown Bag ChatJoin us for LIVE webinars with OncoLink's cancer experts and have your questions addressed. You can submit questions during the chat or ahead of time. Submit a Question Now!. Transcripts will be available after the events in case you miss one.

Upcoming Webinars & Webchats

Mously LeBlanc, MD

Webinar: Cancer Rehabilitation for Head & Neck Cancers

Join us for this live or archived webinar on Cancer Rehabilitation for Head & Neck Cancers on March 4, 2015 from 10AM-11:15AM.

Webinar: Cancer Rehabilitation for Head & Neck Cancers
by OncoLink Editorial Team

Coping with Grief and Loss During the Holidays [Webinar]
by OncoLink Editorial Team

OncoLink’s Annual Insurance Education Session [Webinar]
by OncoLink Editorial Team

Nutritional Strategies for the Management of Lower Gastrointestinal (GI) Side Effects of Cancer Treatment [Webinar]
by OncoLink Editorial Team

Proton Therapy for Pediatric Cancer [Webinar]
by OncoLink Editorial Team


View all Webinars Web Chat RSS Feed

Cancer Awareness

Prevención Nacional del Cáncer

Visite el menú de OncoLink sobre Causas y Prevención para los ultimos recursos y  información del cáncer referente a factores ambientales relacionados con cáncer, temas sobre el fumar y el tabaco, dieta, hormonas y factores genéticos.

Redactores Bien escogidosConcesión Escogida por el Redactor Febrero del 2005
Esta concesión es dada por los redactores de OncoLink a los abastecedores de  información de cáncer de calidad más alta en el Internet. El premidado de este mes es El instituto Americano para la Investigación de Cáncer.


In the News

Genetic Mutations Found in Leukemia Rise With Age

Today - For many people, an increase in genetic mutations that could trigger leukemia seems to be an inevitable part of aging, according to a new study published online Feb. 26 in Cell Reports.


Oral Bisphosphonate Use Tied to Lower Endometrial Cancer Risk

Today - For postmenopausal women, oral bisphosphonate use is associated with a reduction in the risk of endometrial cancer, according to a study published online Feb. 23 in the Journal of Clinical Oncology.


Researchers Examine Etiology of Ibrutinib Discontinuation in CLL

Feb 27, 2015 - For patients with chronic lymphocytic leukemia, the Bruton tyrosine kinase inhibitor ibrutinib is effective, and prognosis is poor after discontinuation, according to a study published online Feb. 26 in JAMA Oncology. The research identifies, for the first time, baseline factors associated with ibrutinib therapy discontinuation.


Read More Cancer News

Skin cream usage for radiation-related skin reactions: An internet-based survey

Skin cream usage for radiation-related skin reactions: An internet-based survey Please help us to better understand skin cream usage for patients who develop skin redness/irritation during radiation therapy. We are very interested in the opinions and experience of both patients and providers regarding skin cream usage for radiation-related skin reactions. Your participation in this survey would be much appreciated.

I Wish U Knew!

I Wish U Knew es una serie video con profesionales de la oncología y los sobrevivientes hablan sobre lo que quieren los pacientes y el público sabía sobre el cáncer.

What every person should know about screening, learning about your disease and the importance of cllinical research.

View More